Powdered Glutamic Acid Polymer Thickener for Salt-Stable Topicals

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current topical pharmaceutical compositions rely on petrochemical-based polymers for thickening, which are not sustainable and require complex implementation, making it difficult to use naturally derived polymers effectively in polar media.

Innovation Solution

A process for preparing a topical pharmaceutical composition using 100% powdered solid polymers derived from partially or totally salified glutamic acid, crosslinked with agents bearing glycidyl groups, and spray-dried at specific temperatures to enhance thickening properties in aqueous phases.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If petrochemical-based polymers are used as thickening agents, then high viscosity and rheology modification are achieved, but sustainability and environmental friendliness deteriorate

Engineering Contradiction:
Improvethickening performanceVSAvoidenvironmental sustainability
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the chemical origin parameter from petrochemical to renewable resources (glutamic acid, glucose, arabinose, xylose, galactose, mannose, ribose, glucuronic acid, amino acids). This parameter change maintains the thickening function while improving environmental sustainability by using biodegradable, renewable monomers that can be produced through fermentation or natural extraction.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates composite polymer structures by combining multiple monomer types (e.g., glutamic acid with crosslinking agents, or sugar-derived monomers with amino acid monomers). These composite polymers achieve enhanced thickening performance and rheology modification while maintaining biodegradability and sustainability through their natural monomer composition.

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If naturally derived polymers are used, then sustainability is improved, but thickening performance and viscosity increase are insufficient

Engineering Contradiction:
Improveenvironmental sustainabilityVSAvoidthickening performance
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent performs preliminary chemical modification of naturally derived monomers through crosslinking reactions before polymer formation. By pre-functionalizing the monomers with crosslinking agents (e.g., polyepoxide derivatives, isocyanates, or silane compounds), the resulting polymer network achieves enhanced thickening performance and viscosity while maintaining the sustainable, biodegradable nature of the original monomers.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent combines naturally derived monomers (glutamic acid, sugar derivatives, amino acids) with crosslinking agents to create composite polymer networks. This composite approach leverages the sustainability of natural monomers while the crosslinked network structure provides enhanced thickening performance and rheology modification, resolving the performance-deficiency of simple natural polymers.

Inventive Principle:
Principle #40Composite materials

3Reliability

If crosslinking reactions are performed to enhance thickening, then viscosity and gel formation are improved, but process complexity and implementation difficulty increase

Engineering Contradiction:
Improvegel formation capabilityVSAvoidprocess implementation
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent incorporates crosslinking functionality into the monomer design itself, performing the crosslinking action during polymerization rather than as a separate subsequent step. By using monomers that contain both polymerization and crosslinking functional groups, the process achieves gel formation and enhanced thickening in a single integrated reaction, reducing process complexity and implementation difficulty.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent introduces crosslinking agents as intermediaries that facilitate the formation of polymer networks under mild conditions. These intermediaries (such as polyepoxide derivatives or silane compounds) enable crosslinking reactions to proceed efficiently with simple mixing and heating, avoiding complex multi-step procedures while achieving the desired gel formation and thickening performance.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The process results in a composition that easily thickens aqueous phases, achieving high viscosities even in the presence of salts, providing a sustainable and efficient alternative to petrochemical-based polymers.

Implementation Method 1

The crosslinking of polymer chains aims to link several polymer chains together, which, when added to a polar phase, and more specifically to water, form a three-dimensional network that is insoluble in water but swells in water, thus leading to the formation of a chemical gel.

Methodology Applied
Scientific EffectCrosslinking: Chemical Bonding

Implementation Method 2

form a three-dimensional network that is insoluble in water but swells in water, thus leading to the formation of a chemical gel

Methodology Applied
Scientific EffectGel formation: Gel

Implementation Method 3

c) spray-drying the polar phase from step (b)

Methodology Applied
Scientific EffectEvaporation: Evaporation

Data Source

PatentEP4259092B1Process for the preparation of a pharmaceutical composition for topical use comprising a polymer in the form of a pulverulent solid as thickening agent
Publication Date: 2026.02.18 SOC DEXPLOITATION DE PROD POUR LES IND CHEM SEPPIC
  • EP4259092B1 patent drawing
  • EP4259092B1 patent drawing
  • EP4259092B1 patent drawing

AI summary

Disclosed is a pharmaceutical composition (F) for topical use, comprising at least one active pharmaceutical ingredient and, as thickening agent, a polymer (P) in the form of a pulverulent solid consisting of monomeric units derived from partially or totally salified glutamic acid (GA), and monomer units of at least one crosslinking agent (AR) having at least two glycidyl functions.